conferences call-proposals 
pharmaphorum
JUNE 21, 2022
While proponents argue waiving IP on COVID-19 vaccines would better enable low- and middle-income countries to inoculate their populations, the pharma industry has called the proposals “unnecessary and harmful to innovation”. Since then, then IP framework has “fallen victim of political posturing”, it claims. Accelerating roll out.
European Pharmaceutical Review
JULY 29, 2022
Both the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) have endorsed a statement calling for international collaboration on integrating real-world evidence (RWE) into regulatory decision-making. Related regulatory news: EU proposes new blood, tissues and cells Regulation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 21, 2022
The biotech hasn’t revealed much information about the reasons for the delay in getting approval, but said in an SEC filing in June this year that it had agreed to “post-marketing commitments” proposed by the FDA, without going into details.
pharmaphorum
DECEMBER 16, 2022
During a recent address at a conference on the lessons learned from COVID-19, the WHO regional director for Europe, Hans Kluge, outlined a global target for an approach called 7-1-7, which he noted had received ‘significant interest’. The aim of this initiative is to speed up the response to potential threats.
pharmaphorum
MARCH 17, 2022
The antibody reduced amyloid beta plaque levels out to week 132 of treatment, and also cut plasma levels of a biomarker protein called p-tau181 at week 128, according to a presentation of the data at the International Conference on Alzheimer’s and Parkinson’s Diseases. There are signs of opposition to that stance.
Pharmaceutical Technology
JANUARY 31, 2023
FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. Accelerated approvals are really important to society and patient populations, and industry,” Califf told the JP Morgan Conference. “[But]
pharmaphorum
OCTOBER 12, 2022
They hope the conference will provide an opportunity to get their message out to a new group of influencers in the ongoing digital transformation of healthcare. “So, And this is what we call, not policymaking for sure, but it’s creating sufficient critical mass to help in shaping policy.”.
Expert insights. Personalized for you.
98 
Let's personalize your content